Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center

New melanoma therapies have shifted the expectations of patients and providers. Evaluating the impact of treatment characteristics may enhance shared decision making. A survey, including a discrete choice experiment, was utilized to evaluate perceived trade-offs of different melanoma treatments and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenehjem, David D., Au, Trang H., Ngorsuraches, Surachat, Ma, Junjie, Bauer, Hillevi, Wanishayakorn, Tanatape, Nelson, Ryan S., Pfeiffer, Constance M., Schwartz, Joshua, Korytowsky, Beata, Oderda, Gary, Brixner, Diana I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887632/
https://www.ncbi.nlm.nih.gov/pubmed/30688762
http://dx.doi.org/10.1097/CMR.0000000000000572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887632/
https://www.ncbi.nlm.nih.gov/pubmed/30688762
http://dx.doi.org/10.1097/CMR.0000000000000572

Ejemplares similares